Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical losartan versus placebo for improvement of surgical scar
IRCT20120215009014N453Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in surgical scar comparing Losartan topical ointment with Placebo ointment (eucerin) (2 arms). Primary endpoint: Improvement of surgical scar. Started Jan 2023; status: completed.
02
Drugs
losartan
03
Conditions
surgical scar
Beyond the preview
Go deeper on IRCT20120215009014N453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N453.